Observational study / 2003
Plasma omega-3 fatty acids were not linked to a lower risk of cognitive impairment or dementia in older adults.
Researchers analyzed data from subjects aged 65 or older participating in the Canadian Study of Health and Aging to evaluate plasma phospholipid omega-3 fatty acid levels and cognitive outcomes. Cross-sectional analysis found no significant difference in omega-3 concentrations between controls and prevalent cases of cognitive impairment or dementia. Prospectively, cognitively impaired cases had higher eicosapentaenoic acid (p < 0.01) than controls, while dementia cases had higher docosahexaenoic acid (p < 0.07), omega-3 (p < 0.04), and total polyunsaturated fatty acid (p < 0.03) concentrations. These findings do not support a protective role for omega-3 fatty acids against cognitive decline or dementia.
Shows an association, not proof of cause and effect.
- Study type
- Cross-sectional and prospective cohort analysis
- Who was studied
- Subjects 65 years or older with complete clinical evaluations at two waves of the Canadian Study of Health and Aging
- What was measured
- Prevalence and incidence of cognitive impairment and dementia by baseline plasma phospholipid fatty acid concentrations
THE PAPER
Omega-3 fatty acids and risk of cognitive impairment and dementia.
Laurin D, Verreault R, Lindsay J, Dewailly E, Holub BJ. J Alzheimers Dis, 2003.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.